These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9613886)

  • 41. HAS-BLED Predicts Warfarin Control in Australian Patients treated for Deep Vein Thrombosis.
    Mueller K; Bernaitis N; Badrick T; Anoopkumar-Dukie S
    Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):299-302. PubMed ID: 27718518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of Kidney Transplant Status on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage.
    Yanik MV; Irvin MR; Beasley TM; Jacobson PA; Julian BA; Limdi NA
    Pharmacotherapy; 2017 Nov; 37(11):1366-1373. PubMed ID: 28949423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.
    Quinn GR; Singer DE; Chang Y; Go AS; Borowsky LH; Udaltsova N; Fang MC
    Am J Cardiol; 2014 Aug; 114(4):583-6. PubMed ID: 25001151
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.
    Fang MC; Go AS; Chang Y; Borowsky LH; Pomernacki NK; Udaltsova N; Singer DE
    J Am Coll Cardiol; 2011 Jul; 58(4):395-401. PubMed ID: 21757117
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota.
    Gitter MJ; Jaeger TM; Petterson TM; Gersh BJ; Silverstein MD
    Mayo Clin Proc; 1995 Aug; 70(8):725-33. PubMed ID: 7630209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the Safety and Effectiveness of Apixaban versus Warfarin in Patients with Severe Renal Impairment.
    Stanton BE; Barasch NS; Tellor KB
    Pharmacotherapy; 2017 Apr; 37(4):412-419. PubMed ID: 28117916
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: a prospective cohort study.
    Limdi NA; Nolin TD; Booth SL; Centi A; Marques MB; Crowley MR; Allon M; Beasley TM
    Am J Kidney Dis; 2015 May; 65(5):701-9. PubMed ID: 25468385
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of thromboembolic events after protocolized warfarin reversal with 3-factor PCC and factor VIIa.
    Barton CA; Johnson NB; Case J; Warden B; Hughes D; Zimmerman J; Roberti G; McMillian WD; Schreiber M
    Am J Emerg Med; 2015 Nov; 33(11):1562-6. PubMed ID: 26143317
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation.
    Gulløv AL; Koefoed BG; Petersen P
    Arch Intern Med; 1999 Jun; 159(12):1322-8. PubMed ID: 10386508
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gastrointestinal hemorrhage in warfarin anticoagulated patients: incidence, risk factor, management, and outcome.
    Chen WC; Chen YH; Hsu PI; Tsay FW; Chan HH; Cheng JS; Lai KH
    Biomed Res Int; 2014; 2014():463767. PubMed ID: 24987683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcomes of anticoagulated trauma patients.
    Ferrera PC; Bartfield JM
    Am J Emerg Med; 1999 Mar; 17(2):154-6. PubMed ID: 10102316
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bleeding complications associated with warfarin treatment in ischemic stroke patients with atrial fibrillation: a population-based cohort study.
    Seet RC; Rabinstein AA; Christianson TJ; Petty GW; Brown RD
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):561-9. PubMed ID: 23499334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study.
    Medina A; Raskob G; Ageno W; Cohen AT; Brekelmans MPA; Chen CZ; Grosso MA; Mercuri MF; Segers A; Verhamme P; Vanassche T; Wells PS; Lin M; Winters SM; Weitz JI; Büller HR
    Thromb Haemost; 2017 Dec; 117(12):2406-2414. PubMed ID: 29212128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Benefits and risks of anticoagulation resumption following traumatic brain injury.
    Albrecht JS; Liu X; Baumgarten M; Langenberg P; Rattinger GB; Smith GS; Gambert SR; Gottlieb SS; Zuckerman IH
    JAMA Intern Med; 2014 Aug; 174(8):1244-51. PubMed ID: 24915005
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety and low molecular weight heparin in older people in a hospital with ambulatory care.
    Chan DK; Ong B; Almafragy H; Karr M; Hung AW; Liu JG
    Arch Gerontol Geriatr; 2006; 43(2):233-41. PubMed ID: 16359739
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Warfarin and phenprocoumon: experience of an outpatient anticoagulation clinic].
    Leiria TL; Pellanda L; Miglioranza MH; Sant'anna RT; Becker LS; Magalhães E; Lima GG
    Arq Bras Cardiol; 2010 Jan; 94(1):41-5. PubMed ID: 20414525
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
    Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
    Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk of bleeding during long-term anticoagulation with warfarin: a tertiary care center experience.
    Khan F; Datta YH
    Blood Coagul Fibrinolysis; 2015 Jan; 26(1):110-2. PubMed ID: 25158989
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risks of long-term oral anticoagulation in a non-trial medical environment.
    McKenna CJ; Galvin J; McCann HA; Sugrue DD
    Ir Med J; 1996; 89(4):144-5. PubMed ID: 8824039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.